Semaglutide Cost Breakdown: Brand, Compounded, Insurance & Savings Options

Introduction

The cash price of brand semaglutide in the US is roughly $1,300 per month for Wegovy® and $1,000 per month for Ozempic® without insurance. Compounded semaglutide from a 503A or 503B pharmacy typically runs $150 to $400 per month. Insurance coverage varies widely. Some plans cover Wegovy for obesity, most cover Ozempic for type 2 diabetes, and Medicare still doesn’t cover GLP-1 drugs for weight loss alone as of 2026.

This article breaks down each price point, what’s driving it, how insurance approvals work, and the realistic savings strategies. Novo Nordisk’s manufacturer programs, employer carve-outs, telehealth compounding, and direct purchase channels all offer different prices for the same molecule.

The numbers shift over time as patents, supply constraints, and policy decisions move. Compounded semaglutide pricing in particular has changed multiple times since the FDA removed semaglutide from the shortage list in 2024 and then dealt with ongoing manufacturer disputes.

At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.

What Does Brand Semaglutide Cost Without Insurance?

Wegovy’s list price is $1,349 per month in 2026. Ozempic’s list price is $968 per month. Real retail prices at pharmacies often run higher because of markups: $1,500 to $1,700 for Wegovy is common, and Ozempic frequently runs $1,000 to $1,200 cash.

Quick Answer: Brand Wegovy cash price: $1,300/month list, often $1,600+ at retail

These prices haven’t moved much since launch despite calls for reductions. Novo Nordisk has cited research and development costs, manufacturing complexity, and the public health value of the drug. Critics point out that the same molecule sells for much less in other countries: about $90 per month in France, $59 in Germany, and $99 in the UK.

Cash-pay patients in the US often use GoodRx, SingleCare, or pharmacy-specific coupons to shave 10 to 20% off list. The savings are modest because pharmacy benefit managers negotiate most of the actual price reduction through rebates that don’t reach uninsured patients.

What Does Compounded Semaglutide Cost?

Compounded semaglutide pricing has fluctuated significantly. During the FDA shortage period (2022 to 2024), prices ran $250 to $500 per month at most telehealth services. After the shortage resolved and FDA restrictions tightened on compounding, some services raised prices while others narrowed offerings.

As of 2026, typical compounded semaglutide pricing through legitimate telehealth platforms runs:

• $150 to $200 per month at the introductory dose phase (0.25 to 0.5 mg)
• $200 to $350 per month at mid doses (1.0 to 1.7 mg)
• $300 to $400 per month at full maintenance dose (2.4 mg)

TrimRx works with FDA-registered 503B outsourcing facilities and offers transparent pricing with no surprise charges. The free assessment quiz determines eligibility before any payment is required.

Some compounded preparations include vitamin B12 or pyridoxine (B6) at no extra cost. These additives don’t change the semaglutide cost but can help with nausea or fatigue.

What Does Insurance Cover?

Commercial insurance coverage for semaglutide depends heavily on the indication. Type 2 diabetes coverage (Ozempic, Rybelsus®) is nearly universal on commercial plans with prior authorization. Weight loss coverage (Wegovy) is more restricted.

A 2024 Mercer survey found about 47% of large employers cover GLP-1 drugs for obesity, up from 26% in 2022. Coverage requirements typically include BMI over 30, or BMI over 27 with comorbidities like type 2 diabetes, hypertension, or sleep apnea. Documented prior attempts at weight loss are often required.

Step therapy is common. Many plans require trying older, cheaper drugs (orlistat, phentermine, naltrexone-bupropion, liraglutide) before approving semaglutide. Some plans require ongoing weight loss documentation (typically 5% loss at 6 months) to continue coverage.

Does Medicare Cover Semaglutide?

Medicare Part D covers semaglutide for type 2 diabetes (as Ozempic or Rybelsus) and for cardiovascular risk reduction in patients with established cardiovascular disease and overweight or obesity (a 2024 CMS clarification based on the SELECT indication).

Medicare does not cover semaglutide for weight loss alone. Federal law (the Medicare Modernization Act of 2003) prohibits coverage of drugs for weight loss. The Treat and Reduce Obesity Act has been introduced multiple times to change this but has not passed as of 2026.

Medicare beneficiaries who want semaglutide for weight loss alone are in the cash-pay market, where compounded options or manufacturer assistance programs are typically the only affordable route.

What Does Medicaid Cover?

Medicaid coverage varies by state. As of 2026, about 13 states cover Wegovy for weight loss with prior authorization. Most states cover Ozempic for diabetes. The patchwork makes coverage state-specific and prone to change with state budgets.

For patients on Medicaid who don’t have diabetes, compounded semaglutide may be more affordable than out-of-pocket brand, though some states explicitly restrict patients from using telehealth compounding while enrolled in Medicaid.

State Medicaid pharmacy benefit pages, or a call to the state’s pharmacy assistance line, usually clarify current coverage. Coverage rules often change between fiscal years.

What Are the Manufacturer Savings Programs?

Novo Nordisk offers a Wegovy savings card for commercial insurance patients that can bring out-of-pocket costs to as low as $0 per month, capped at $200 to $225 in some cases. The card has annual maximum savings and isn’t available to Medicare, Medicaid, TRICARE, or VA patients.

The same card structure exists for Ozempic, with caps and exclusions. The fine print matters: most cards require coverage of the medication by the patient’s primary insurance, just at high out-of-pocket cost. They don’t fill gaps for plans that exclude the drug entirely.

A separate Novo Nordisk Patient Assistance Program offers free medication for patients without insurance who meet income criteria (typically under 400% of federal poverty level). The application requires income documentation and physician sign-off.

How Does Compounded Compare on Cost?

For most uninsured or underinsured patients, compounded semaglutide is dramatically cheaper than brand. A patient at full maintenance dose pays about $300 to $400 per month compounded vs $1,300+ for Wegovy.

The price difference reflects several factors: compounding pharmacies don’t carry the same regulatory burden as a new drug application, they buy API directly from FDA-registered manufacturers at lower prices, they don’t pay PBM rebates or wholesaler markups, and they don’t carry the marketing costs that brand drugs build into their prices.

Compounded semaglutide isn’t FDA-approved as a specific finished product, but the pharmacies that prepare it are state-licensed (503A) or FDA-registered (503B) and operate under USP 797 sterility standards. The active ingredient comes from FDA-registered API manufacturers.

Key Takeaway: Compounded semaglutide via telehealth: $150 to $400/month

What About International Pricing Options?

Some US patients buy semaglutide from Canadian or international pharmacies. The legal situation is gray for personal importation, with most enforcement focused on commercial schemes rather than individual purchases for personal use. Quality control varies.

Verified Canadian pharmacy services typically run $400 to $600 per month for Ozempic, plus shipping and handling. Wegovy is sometimes harder to obtain through these channels due to ongoing supply constraints in some markets.

Patients traveling abroad sometimes buy directly in countries like France, Germany, or Mexico where prices are dramatically lower. This works for short-term supply but isn’t a sustainable solution for ongoing chronic use.

How Do Telehealth Platforms Structure Pricing?

Telehealth GLP-1 services typically bundle the medical visit, prescription, and medication delivery into a monthly subscription. Common structures include:

• Flat monthly subscription with medication included
• Subscription plus dose-based medication pricing
• Pay-as-you-go pricing per shipment
• Quarterly or annual prepay discounts

TrimRx provides a personalized treatment plan with transparent monthly pricing that includes provider consultations, medication, and shipping. There are no hidden activation fees or surprise charges.

Cancellation policies and refund terms vary significantly between platforms. Reading the terms before signing up is worth the few minutes. Some platforms charge for unused medication if a patient pauses or stops.

Are HSAs and FSAs Eligible?

Both health savings accounts (HSAs) and flexible spending accounts (FSAs) can be used for semaglutide when prescribed for an FDA-approved indication. For Wegovy and Ozempic, that includes weight loss with BMI criteria, type 2 diabetes, and cardiovascular risk reduction.

For compounded semaglutide, HSA/FSA eligibility is generally allowed as long as it’s prescribed by a licensed clinician for a medical purpose. Some HSA administrators may require additional documentation. Receipts and prescription records should be kept for tax purposes.

The pre-tax benefit makes a substantial difference. A patient in the 24% federal tax bracket effectively saves 24% off the cash cost by paying through HSA or FSA dollars. Combined with employer FSA contributions, the effective monthly cost of compounded semaglutide can drop below $200.

What’s the Cost of Staying on Long-term?

Semaglutide is a chronic-disease medication. Stopping after the initial loss phase typically leads to regain. The relevant question for cost planning is annual cost over 5 or 10 years, not just the loss phase.

At brand pricing with no coverage, that’s $15,000 to $20,000 per year. At compounded pricing, it’s $2,500 to $5,000 per year. Even with insurance copays, brand can run $1,000 to $3,000 per year out-of-pocket.

Some clinicians use lower maintenance doses (0.5 to 1.0 mg) after the active loss phase to reduce ongoing cost. There’s no head-to-head trial of maintenance levels, but observational data support this approach for many patients.

What About Employer and Group Coverage Trends?

Employer coverage of GLP-1 drugs for obesity has grown significantly since 2022 but remains uneven. Large employers (5,000+ employees) are more likely to cover than smaller employers, and coverage is more common in industries with younger workforces or unionized contracts.

Some employers are introducing tiered coverage based on documented engagement with lifestyle programs. Coverage may require enrollment in a weight management program, regular check-ins, and demonstrated weight loss to continue coverage past 6 months.

Self-insured employers have more flexibility to design coverage rules than fully insured plans. The trend has been toward broader coverage with conditions rather than blanket exclusion.

Bottom line: Medicare cannot legally cover weight-loss drugs as of 2026 (Treat and Reduce Obesity Act still pending)

FAQ

Is Compounded Semaglutide as Effective as Wegovy?

The active molecule is identical. Clinical effect should be the same when dosed equivalently. The differences are regulatory (compounded is not FDA-approved as a finished product) and in the inactive ingredients. Compounded pharmacies that source API from FDA-registered manufacturers produce a chemically equivalent product.

Why Is Compounded So Much Cheaper?

Lower regulatory burden, no PBM rebates or wholesaler markups, no marketing costs, and direct API sourcing all contribute. Brand drug pricing builds in years of research and development costs plus marketing budgets that compounded operations don’t carry.

Can I Switch Between Brand and Compounded?

Yes. The active molecule is the same, so direct dose-for-dose substitution works. Transitioning from one to the other does not require restarting the titration. Some patients use brand when insurance covers it and compounded as a backup if coverage lapses.

Will Insurance Cover Semaglutide If I Have Prediabetes but Not Type 2 Diabetes?

Sometimes. Coverage depends on the plan, the indication submitted, and any step therapy requirements. Prediabetes with elevated BMI or other comorbidities may qualify under Wegovy’s obesity indication on plans that cover it. Pure prediabetes without weight criteria is often not enough for approval.

Does the Manufacturer Savings Card Stack with Insurance?

Yes, with commercial insurance. The card lowers the patient’s copay after insurance has been billed. It doesn’t work alongside Medicare, Medicaid, TRICARE, or VA benefits due to federal anti-kickback regulations.

How Does Pricing Compare to Tirzepatide?

Tirzepatide pricing follows a similar structure: brand Zepbound® and Mounjaro® cost about $1,000 to $1,300 per month list. Compounded tirzepatide typically runs slightly higher than compounded semaglutide ($300 to $500 per month) due to higher API cost.

What If I Lose Insurance Coverage Mid-treatment?

Compounded semaglutide is often the bridge for patients who lose insurance mid-treatment. Manufacturer patient assistance programs are another option for income-qualified patients. Stopping abruptly typically leads to regain over the following 6 to 12 months, so finding a backup option is worth the effort.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.